ClinConnect ClinConnect Logo
Search / Trial NCT06924580

Early ECG Prediction of Multi-system Disease Cohort Establishment and Follow Up

Launched by RENJI HOSPITAL · Apr 6, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how well an advanced technology called artificial intelligence (AI) can help doctors detect multi-system diseases using electrocardiograms (ECGs), which are tests that measure the heart's electrical activity. The goal is to see if AI can improve the way we diagnose these complex conditions in patients who visit hospitals, emergency rooms, or outpatient clinics. The researchers are currently recruiting participants to join this multicenter study.

To participate, individuals must have received care at the study hospital and have both ECG test results and discharge diagnosis codes. Unfortunately, those who choose not to participate, have missing medical information, or are pregnant will not be eligible. If you join the study, you will help researchers gather important data that could lead to better screening and diagnosis for multi-system diseases in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients who visited the study hospital.
  • 2. Patients included should have both ECG data and discharge diagnosis codes (ICD-10) for inpatients and emergency patients.
  • Exclusion Criteria:
  • 1. Patients who declined participation, cases with incomplete or missing clinical data, and pregnant individuals.

About Renji Hospital

Renji Hospital, a prestigious medical institution affiliated with Shanghai Jiao Tong University School of Medicine, is dedicated to advancing healthcare through innovative clinical research. With a strong emphasis on patient-centered care, Renji Hospital conducts a wide range of clinical trials across various therapeutic areas, harnessing cutting-edge technology and evidence-based practices. The hospital's multidisciplinary team of experienced researchers and medical professionals collaborates closely to ensure rigorous study design and execution, aiming to contribute significantly to medical knowledge and improve treatment outcomes for patients worldwide.

Locations

Shanghai, Shanghai, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported